116 related articles for article (PubMed ID: 11401028)
1. Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images.
Flynn AA; Boxer GM; Begent RH; Pedley RB
Cancer Immunol Immunother; 2001 Apr; 50(2):77-81. PubMed ID: 11401028
[TBL] [Abstract][Full Text] [Related]
2. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
3. Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
Boxer GM; Abassi AM; Pedley RB; Begent RH
Br J Cancer; 1994 Feb; 69(2):307-14. PubMed ID: 7507692
[TBL] [Abstract][Full Text] [Related]
4. Effect of dose escalation of a monoclonal anti-CEA IgG on tumour localisation and tissue distribution in nude mice xenografted with human colon carcinoma.
Rogers GT; Pedley RB; Boden J; Harwood PJ; Bagshawe KD
Cancer Immunol Immunother; 1986; 23(2):107-12. PubMed ID: 3779712
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.
Boxer G; Stuart-Smith S; Flynn A; Green A; Begent R
Br J Cancer; 1999 May; 80(5-6):922-6. PubMed ID: 10360677
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinoma.
Rajkumar VS; Boxer G; Robson M; Muddle J; Papastavrou Y; Pedley RB
Tumour Biol; 2012 Dec; 33(6):2019-29. PubMed ID: 22833213
[TBL] [Abstract][Full Text] [Related]
7. The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts.
Lewis JC; Boxer GM; Searle F; Bagshawe KD
Tumour Biol; 1984; 5(5):255-61. PubMed ID: 6397841
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
Turner JH; Rose AH; Glancy RJ; Penhale WJ
Br J Cancer; 1998 Aug; 78(4):486-94. PubMed ID: 9716032
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
Esteban JM; Kuhn JA; Felder B; Wong JY; Battifora H; Beatty JD; Wanek PM; Shively JE
Cancer Res; 1991 Jul; 51(14):3802-6. PubMed ID: 2065334
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
[TBL] [Abstract][Full Text] [Related]
11. A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology.
Flynn AA; Green AJ; Boxer G; Pedley RB; Begent RH
Phys Med Biol; 1999 Jul; 44(7):N151-9. PubMed ID: 10442718
[TBL] [Abstract][Full Text] [Related]
12. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.
Boxer GM; Begent RH; Kelly AM; Southall PJ; Blair SB; Theodorou NA; Dawson PM; Ledermann JA
Br J Cancer; 1992 Jun; 65(6):825-31. PubMed ID: 1616854
[TBL] [Abstract][Full Text] [Related]
14. Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice.
Mittal BB; Zimmer AM; Sathiaseelan V; Rosen ST; Radosevich JA; Rademaker AW; Saini A; Pierce MC; Webber DI; Spies SM
Cancer; 1992 Dec; 70(12):2785-91. PubMed ID: 1451056
[TBL] [Abstract][Full Text] [Related]
15. The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft model.
Pedley RB; Begent RH; Boden JA; Boden R; Adam T; Bagshawe KD
Int J Cancer; 1991 Feb; 47(4):597-602. PubMed ID: 1995488
[TBL] [Abstract][Full Text] [Related]
16. The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
Pedley RB; Boden JA; Boden RW; Green A; Boxer GM; Bagshawe KD
Br J Cancer; 1989 Oct; 60(4):549-54. PubMed ID: 2803924
[TBL] [Abstract][Full Text] [Related]
17. The spatial distribution of parenterally administered monoclonal antibodies against CEA in a human colorectal tumour xenograft.
Ahlström H; Enblad P; Andersson A; Lörelius LE
Acta Oncol; 1989; 28(1):81-6. PubMed ID: 2706137
[TBL] [Abstract][Full Text] [Related]
18. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.
Folli S; Pèlegrin A; Chalandon Y; Yao X; Buchegger F; Lienard D; Lejeune F; Mach JP
Int J Cancer; 1993 Mar; 53(5):829-36. PubMed ID: 8449608
[TBL] [Abstract][Full Text] [Related]
19. Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine.
Smith W; Gore VA; Brandon DR; Lynch DN; Cranstone SA; Corvalan JR
Cancer Immunol Immunother; 1990; 31(3):157-63. PubMed ID: 2186853
[TBL] [Abstract][Full Text] [Related]
20. Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas.
Blumenthal RD; Sharkey RM; Kashi R; Natale AM; Goldenberg DM
Int J Cancer; 1992 Jul; 51(6):935-41. PubMed ID: 1322378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
